المؤلفون: Tewari, K, Monk, B, Vergote, I, Miller, A, De Melo, AC, Kim, HS, Kim, YM, Lisyanskaya, A, Samouelian, V, Lorusso, D, Damian, F, Chang, C-L, Gotovkin, EA, Takahashi, S, Ramone, D, Pikiel, J, Li, J, Mathias, M, Fury, MG, Oaknin, A

المصدر: Oral Abstracts

الإتاحة: https://doi.org/10.1136/ijgc-2021-igcs.1Test

المؤلفون: Lorusso, D, Vergote, I, Oaknin, A, Tewari, KS, De Melo, AC, Kim, HS, Kim, YM, Lisyanskaya, A, Damian, F, Chang, CL, Rischin, D, Takahashi, S, Ramone, D, Pikiel, J, Guerra Alía, EM, LI, J, Jamil, S, Mathias, M, Fury, MG, Monk, BJ

المصدر: Cervical cancer

الإتاحة: https://doi.org/10.1136/ijgc-2021-esgo.14Test

المؤلفون: Fury, MG, Sherman, EJ, Rao, SS, Wolden, S, Smith-Marrone, S, Mueller, B, Ng, KK, Dutta, PR, Gelblum, DY, Lee, JL, Shen, R, Kurz, S, Katabi, N, Haque, S, Lee, NY, Pfister, DG

المصدر: Annals of Oncology. 25(3)

مصطلحات موضوعية: Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, Clinical Trials and Supportive Activities, Clinical Research, Cancer, Infectious Diseases, Dental/Oral and Craniofacial Disease, 6.5 Radiotherapy and other non-invasive therapies, Evaluation of treatments and therapeutic interventions, 6.1 Pharmaceuticals, Aged, Aged, 80 and over, Albumins, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Phytogenic, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Squamous Cell, Cetuximab, Chemoradiotherapy, Combined Modality Therapy, ErbB Receptors, Female, Head and Neck Neoplasms, Humans, Male, Maximum Tolerated Dose, Middle Aged, Neoplasm Staging, Paclitaxel, Radiotherapy, Intensity-Modulated, Squamous Cell Carcinoma of Head and Neck, 6.5 Radiotherapy, cetuximab, head and neck, nab-paclitaxel, radiation, squamous, Oncology & Carcinogenesis, Clinical sciences, Oncology and carcinogenesis

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/3v78q20sTest

المؤلفون: Paccaly, AJ, Migden, MR, Papadopoulos, KP, Yang, F, Davis, JD, Rippley, RK, Lowy, I, Fury, MG, Stankevich, E, Rischin, D

العلاقة: pii: 10.1007/s12325-021-01638-5; Paccaly, A. J., Migden, M. R., Papadopoulos, K. P., Yang, F., Davis, J. D., Rippley, R. K., Lowy, I., Fury, M. G., Stankevich, E. & Rischin, D. (2021). Fixed Dose of Cemiplimab in Patients with Advanced Malignancies Based on Population Pharmacokinetic Analysis. ADVANCES IN THERAPY, 38 (5), pp.2365-2378. https://doi.org/10.1007/s12325-021-01638-5Test.; http://hdl.handle.net/11343/278220Test

الإتاحة: https://doi.org/10.1007/s12325-021-01638-5Test
http://hdl.handle.net/11343/278220Test

المؤلفون: Rischin, D, Khushalani, N, Schmults, CD, Guminski, A, Chang, ALS, Lewis, KD, Lim, AM, Hernandez-Aya, L, Hughes, BGM, Schadendorf, D, Hauschild, A, Thai, AA, Stankevich, E, Booth, J, Yoo, S-Y, Li, S, Chen, Z, Okoye, E, Chen, C, Mastey, V, Sasane, M, Lowy, I, Fury, MG, Migden, MR

العلاقة: pii: jitc-2021-002757; Rischin, D., Khushalani, N., Schmults, C. D., Guminski, A., Chang, A. L. S., Lewis, K. D., Lim, A. M., Hernandez-Aya, L., Hughes, B. G. M., Schadendorf, D., Hauschild, A., Thai, A. A., Stankevich, E., Booth, J., Yoo, S. -Y., Li, S., Chen, Z., Okoye, E., Chen, C. ,. Migden, M. R. (2021). Integrated analysis of a phase 2 study of cemiplimab in advanced cutaneous squamous cell carcinoma: extended follow-up of outcomes and quality of life analysis. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 9 (8), https://doi.org/10.1136/jitc-2021-002757Test.; http://hdl.handle.net/11343/287788Test

الإتاحة: https://doi.org/10.1136/jitc-2021-002757Test
http://hdl.handle.net/11343/287788Test

المؤلفون: Rischin, D, Migden, MR, Lim, AM, Schmults, CD, Khushalani, N, Hughes, BGM, Schadendorf, D, Dunn, LA, Hernandez-Aya, L, Chang, ALS, Modi, B, Hauschild, A, Ulrich, C, Eigentler, T, Stein, B, Pavlick, AC, Geiger, JL, Gutzmer, R, Alam, M, Okoye, E, Mathias, M, Jankovic, V, Stankevich, E, Booth, J, Li, S, Lowy, I, Fury, MG, Guminski, A

العلاقة: pii: jitc-2020-000775; Rischin, D., Migden, M. R., Lim, A. M., Schmults, C. D., Khushalani, N., Hughes, B. G. M., Schadendorf, D., Dunn, L. A., Hernandez-Aya, L., Chang, A. L. S., Modi, B., Hauschild, A., Ulrich, C., Eigentler, T., Stein, B., Pavlick, A. C., Geiger, J. L., Gutzmer, R., Alam, M. ,. Guminski, A. (2020). Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 8 (1), https://doi.org/10.1136/jitc-2020-000775Test.; http://hdl.handle.net/11343/244754Test

الإتاحة: https://doi.org/10.1136/jitc-2020-000775Test
http://hdl.handle.net/11343/244754Test

المؤلفون: Rischin, D, Gil-Martin, M, Gonzalez-Martin, A, Brana, I, Hou, JY, Cho, D, Falchook, GS, Formenti, S, Jabbour, S, Moore, K, Naing, A, Papadopoulos, KP, Baranda, J, Fury, W, Feng, M, Stankevich, E, Li, J, Yama-Dang, NA, Yoo, S-Y, Lowy, I, Mathias, M, Fury, MG

العلاقة: pii: S0090-8258(20)33827-0; Rischin, D., Gil-Martin, M., Gonzalez-Martin, A., Brana, I., Hou, J. Y., Cho, D., Falchook, G. S., Formenti, S., Jabbour, S., Moore, K., Naing, A., Papadopoulos, K. P., Baranda, J., Fury, W., Feng, M., Stankevich, E., Li, J., Yama-Dang, N. A., Yoo, S. -Y. ,. Fury, M. G. (2020). PD-1 blockade in recurrent or metastatic cervical cancer: Data from cemiplimab phase I expansion cohorts and characterization of PD-L1 expression in cervical cancer. GYNECOLOGIC ONCOLOGY, 159 (2), pp.322-328. https://doi.org/10.1016/j.ygyno.2020.08.026Test.; http://hdl.handle.net/11343/273788Test

الإتاحة: https://doi.org/10.1016/j.ygyno.2020.08.026Test
http://hdl.handle.net/11343/273788Test

المؤلفون: Migden, MR, Khushalani, NI, Chang, ALS, Lewis, KD, Schmults, CD, Hernandez-Aya, L, Meier, F, Schadendorf, D, Guminski, A, Hauschild, A, Wong, DJ, Daniels, GA, Berking, C, Jankovic, V, Stankevich, E, Booth, J, Li, S, Weinreich, DM, Yancopoulos, GD, Lowy, I, Fury, MG, Rischin, D

العلاقة: pii: S1470-2045(19)30728-4; Migden, M. R., Khushalani, N. I., Chang, A. L. S., Lewis, K. D., Schmults, C. D., Hernandez-Aya, L., Meier, F., Schadendorf, D., Guminski, A., Hauschild, A., Wong, D. J., Daniels, G. A., Berking, C., Jankovic, V., Stankevich, E., Booth, J., Li, S., Weinreich, D. M., Yancopoulos, G. D. ,. Rischin, D. (2020). Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial. LANCET ONCOLOGY, 21 (2), pp.294-305. https://doi.org/10.1016/S1470-2045Test(19)30728-4.; http://hdl.handle.net/11343/273444Test

الإتاحة: https://doi.org/10.1016/S1470-2045Test(19)30728-4
http://hdl.handle.net/11343/273444Test

المؤلفون: Fury MG (AUTHOR), Sherman E (AUTHOR), Ho A (AUTHOR), Katabi N (AUTHOR), Sima C (AUTHOR), Kelly KW (AUTHOR), Nwankwo O (AUTHOR), Haque S (AUTHOR), Pfister DG (AUTHOR), Fury, Matthew G¹ (AUTHOR), Sherman, Eric (AUTHOR), Ho, Alan (AUTHOR), Katabi, Nora (AUTHOR), Sima, Camelia (AUTHOR), Kelly, Katherine W (AUTHOR), Nwankwo, Oby (AUTHOR), Haque, Sofia (AUTHOR), Pfister, David G (AUTHOR)

المصدر: Cancer Chemotherapy & Pharmacology. Jul2012, Vol. 70 Issue 1, p121-128. 8p.

المؤلفون: Fury MG (AUTHOR), Sherman E (AUTHOR), Haque S (AUTHOR), Korte S (AUTHOR), Lisa D (AUTHOR), Shen R (AUTHOR), Wu N (AUTHOR), Pfister D (AUTHOR)

المصدر: Cancer Chemotherapy & Pharmacology. Mar2012, Vol. 69 Issue 3, p591-598. 8p.